Cell Robotics to Participate in Discovery Expo '98.ALBUQUERQUE, N. M.--(BUSINESS WIRE)--June 17, 1998--Cell Robotics International, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). : CRII CRII Cooperative Research in Information Infrastructure CRII Customer Returns Improvement Initiative ) will be among 80 companies gathering June 18 at Discovery Expo at the New York Hilton and Towers. This one-day event is the fifth in a series of Discovery Expos organized by The Investment Reporter, a Newport Beach, CA-based financial newspaper, to introduce undiscovered companies to growth fund managers, analysts, stockbrokers and investors. At this time, CRII's Lasette(tm) is the only FDA-cleared laser device designed to nearly painlessly draw blood for glucose testing in diabetic patients. The Lasette uses laser light to produce a small hole in the fingertip for capillary blood collection. A letter of intent was signed on June 10, 1998, with Chronimed, Inc. (Nasdaq: CHMD CHMD Change Mode Command ) for worldwide distribution of the Lasette. The Lasette promises to eliminate cross-contamination accidents from lancet sticks, reduce sharp medical waste, and decrease the trauma associated with steel lancets. The FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. has cleared the Lasette for use on adults in clinical settings. Clinical trials were recently completed for juveniles and home use by all patients. Cell Robotics develops, manufactures and markets additional laser products. One of the company's core technologies is a biotechnology research instrument, the Cell Robotics Workstation, which includes LaserTweezers(r) and LaserScissors(tm), which use laser light to manipulate cells, chromosomes, and DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. molecules for research in cell biology, neuroscience, cancer and plant science. On May 5, 1998, CRII announced the first two pregnancies in the company's clinical trial of its In Vitro Fertilization in vitro fertilization (vē`trō, vĭ`trō), technique for conception of a human embryo outside the mother's body. Several ova, or eggs, are removed from the mother's body and placed in special laboratory culture dishes (Petri dishes); (IVF IVF in vitro fertilization. IVF abbr. in vitro fertilization IVF 1 In vitro fertilization, see there 2. Intravascular fluid ) Workstation. The computer-controlled instrument not only enhances the diagnosis of eggs and embryos before they are chosen for fertilization or implantation, but also incorporates advanced tools for sperm injection and laser-assisted hatching. The IVF Workstation will be demonstrated June 20-24 at the European Society of Human Reproduction and Embryology The European Society of Human Reproduction and Embryology (ESHRE) was created in 1985 by both Professor R.G. Edwards from Cambridge, and Dr. J. Cohen from Paris, who felt that the study and research in the field of reproduction needed to be encouraged and recognized. in Sweden. The instrument has not yet been cleared by the FDA for sale in the United States. Additional information is available on the Cell Robotics Web Site at http://www.cellrobotics.com/cell, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131.
CONTACT: Newport Capital Consultants, Inc.
Gary Bryant, 949/493-9432
or
Craig Rogers, Vice President, Investor Relations,
719/590-1793
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion